[2-(1-azepanyl)-5-methylphenyl]amine dihydrochloride, 95.0%, 5g

K-Ras ligand-Linker Conjugate 6, 100mg

6-Bromopyrimidine-4-carbaldehyde, 95.0%, 100mg

2,4-Difluoro-5-methylbenzenesulfonyl chloride, 95%, 100mg

3-Bromo-5-chloro-6-fluorobenzonitrile, 95.0%, 250mg

Plan PLPHi 20x/0.40 phase contrast IOS infinity corrected objective

Di(naphthalen-1-yl)phosphine oxide, 97.0%, 250mg

3-Bromo-2,4-difluorobenzenesulfonyl chloride, 1g

Methyl 4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 25g

4-(4-Bromo-3-formylphenoxy)benzonitrile, 95.0%, 1g

5-Formylpicolinic acid, 95+%, 10g

3-Difluoromethylphenol, 95.0%, 250mg

4-(Chlorosulfonyl)benzoic acid, 96.0%, 1g